Bio-Techne Corporation P/E Ratio 2009–2025
Bio-Techne Corporation reported 111.17 of price-to-earnings ratio for fiscal 2025. That was 64.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +151.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 111.17 | +64.7% |
| FY 2024 | 67.49 | +47.8% |
| FY 2023 | 45.67 | -10.8% |
| FY 2022 | 51.20 | -59.5% |
| FY 2021 | 126.52 | +186.3% |
| FY 2020 | 44.19 | -45.9% |
| FY 2019 | 81.72 | +90.1% |
| FY 2018 | 42.98 | -22.0% |
| FY 2017 | 55.12 | +45.5% |
| FY 2016 | 37.89 | +19.8% |
| FY 2015 | 31.62 | +11.9% |
| FY 2014 | 28.25 | +38.2% |
| FY 2013 | 20.44 | -5.6% |
| FY 2012 | 21.65 | -10.2% |
| FY 2011 | 24.09 | +43.6% |
| FY 2010 | 16.78 | -13.4% |
| FY 2009 | 19.39 | — |
Source: Bio-Techne Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TECH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bio-Techne Corporation reported 111.17 of price-to-earnings ratio for fiscal 2025. That was 64.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +151.6%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bio-Techne Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Techne Corporation — frequently asked questions
What is Bio-Techne Corporation's price-to-earnings ratio?
Bio-Techne Corporation (TECH) reported price-to-earnings ratio of 111.17 for fiscal year 2025, per its SEC filings.
How has Bio-Techne Corporation's price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, TECH's price-to-earnings ratio grew at roughly 11.5% per year (compound annual rate), from 19.39 to 111.17.
Where does this data come from?
Figures are computed from Bio-Techne Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More TECH financial history
Full TECH fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →